Omega3
Omega3, licence 80118173: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Omega-3 Ultra Strength, Ultra Strength Omega-3
- Licence holder
- Natural Factors Nutritional Products Limited
- NPN or DIN-HM
- 80118173
- Status
- Active licence
- Licence date
- 27 April 2022
- Revision date
- 12 February 2026
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau, Glycérine, Gélatine, Sorbitol, Pectine, Tocophérols
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
| Adultes | minimum: 18.0 Année(s) | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
| Adultes | minimum: 19.0 Année(s) | 3.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps maintain/support (normal) heart/cardiovascular health. Helps support/maintain cognitive health and/or brain function. Helps reduce (blood) triglyceride(s)/triacylglycerol(s) (levels). In conjunction with conventional therapy, helps reduce the pain of rheumatoid arthritis in adults. Helps promote healthy mood balance. Helps promote healthy levels of anti-inflammatory activity. Helps promote a healthy state of anti-inflammatory activity. Helps provide anti-inflammatory support. Helps reduce inflammatory processes in the body Helps support/maintain (normal) heart/cardiovascular function. Helps support/maintain normal (blood) triglyceride/triacylglycerol levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118173
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.